Skip to Content

TWi T112 135mg (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint TWi T112 135mg is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by TWi Pharmaceuticals, Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TWi T112 135mg

Fenofibric Acid Delayed-Release

Imprint
TWi T112 135mg
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
TWi Pharmaceuticals, Inc.
National Drug Code (NDC)
24979-0112

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.